Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma
Authors
Keywords
-
Journal
Cells
Volume 12, Issue 3, Pages 349
Publisher
MDPI AG
Online
2023-01-17
DOI
10.3390/cells12030349
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Elevated SNRPA1, as a Promising Predictor Reflecting Severe Clinical Outcome via Effecting Tumor Immunity for ccRCC, Is Related to Cell Invasion, Metastasis, and Sunitinib Sensitivity
- (2022) Aimin Jiang et al. Frontiers in Immunology
- CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types
- (2022) Aimin Jiang et al. Oxidative Medicine and Cellular Longevity
- Copper induces cell death by targeting lipoylated TCA cycle proteins
- (2022) Peter Tsvetkov et al. SCIENCE
- Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma
- (2022) Haozhen Lv et al. Frontiers in Pharmacology
- System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma
- (2022) Cheng Yan et al. Journal of Translational Medicine
- Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma
- (2022) Fangwei Wang et al. World Journal of Surgical Oncology
- A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma
- (2022) Shujia Chen et al. Frontiers in Immunology
- A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity
- (2022) Jinsong Liu et al. Frontiers in Genetics
- Emerging Targets in Clear Cell Renal Cell Carcinoma
- (2022) Yu-Wei Chen et al. Cancers
- Determining Front-Line Therapeutic Strategy for Metastatic Clear Cell Renal Cell Carcinoma
- (2022) Kevin K. Zarrabi et al. Cancers
- Clinical Significance and Immune Infiltration Analyses of the Cuproptosis-Related Human Copper Proteome in Gastric Cancer
- (2022) Xiaohuan Tang et al. Biomolecules
- Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research
- (2022) Xuhui Tong et al. Journal of Hematology & Oncology
- Comprehensive analysis of cuproptosis-related lncRNAs model in tumor immune microenvironment and prognostic value of cervical cancer
- (2022) Qiang Wang et al. Frontiers in Pharmacology
- A Combined Risk Score Model to Assess Prognostic Value in Patients with Soft Tissue Sarcomas
- (2022) Zihua Li et al. Cells
- Identification and Validation of Glycosyltransferases Correlated with Cuproptosis as a Prognostic Model for Colon Adenocarcinoma
- (2022) Wei Ma et al. Cells
- A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
- (2022) Bixian Luo et al. Frontiers in Oncology
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy
- (2021) Sheera R. Rosenbaum et al. Cancer Discovery
- Mapping the immune environment in clear cell renal carcinoma by single-cell genomics
- (2021) Nicholas Borcherding et al. Communications Biology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
- (2021) David A. Braun et al. CANCER CELL
- Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
- (2021) Robert Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Copper‐Based Nanoscale Coordination Polymers Augmented Tumor Radioimmunotherapy for Immunogenic Cell Death Induction and T‐Cell Infiltration
- (2021) Yuxiang Wang et al. Small
- The role of FDX1 in granulosa cell of Polycystic ovary syndrome (PCOS)
- (2021) Zhi Wang et al. BMC Endocrine Disorders
- PD‐1/PD‐L1 inhibitors‐based treatment for advanced renal cell carcinoma: Mechanisms affecting efficacy and combination therapies
- (2021) Lei Ding et al. Cancer Medicine
- Unleashing TNF cytotoxicity to enhance cancer immunotherapy
- (2021) Andrew J. Freeman et al. TRENDS IN IMMUNOLOGY
- FDX1 can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma
- (2021) Zeyu Zhang et al. Frontiers in Pharmacology
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Checkpoint inhibitor immunotherapy in kidney cancer
- (2020) Wenxin Xu et al. Nature Reviews Urology
- Immunotherapy in Renal Cell Carcinoma: The Future Is Now
- (2020) Antoine Deleuze et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The immunology of renal cell carcinoma
- (2020) C. Marcela Díaz-Montero et al. Nature Reviews Nephrology
- EGFR-AS1 Promotes Bladder Cancer Progression by Upregulating EGFR
- (2020) Anbang Wang et al. Biomed Research International
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mitochondrial metabolism promotes adaptation to proteotoxic stress
- (2019) Peter Tsvetkov et al. Nature Chemical Biology
- Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinoma
- (2019) Chuanjie Zhang et al. Annals of Translational Medicine
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy
- (2018) Fei Yi et al. TRENDS IN MOLECULAR MEDICINE
- The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
- (2018) Christopher J. Ricketts et al. Cell Reports
- Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
- (2018) Rebekka Weber et al. Frontiers in Immunology
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Maftools: efficient and comprehensive analysis of somatic variants in cancer
- (2018) Anand Mayakonda et al. GENOME RESEARCH
- CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma
- (2017) Bernard Escudier et al. EUROPEAN UROLOGY
- Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) Robert J. Motzer et al. Journal of the National Comprehensive Cancer Network
- Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α
- (2016) Yana G. Najjar et al. CLINICAL CANCER RESEARCH
- Renal cancer
- (2016) Umberto Capitanio et al. LANCET
- Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma
- (2016) Fengju Chen et al. Cell Reports
- The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti-PD-1 Response in Patients with Renal Cell Carcinoma
- (2016) M. L. Ascierto et al. Cancer Immunology Research
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Copper is required for oncogenic BRAF signalling and tumorigenesis
- (2014) Donita C. Brady et al. NATURE
- Broadening the phenotype of LRP2 mutations: a new mutation in LRP2 causes a predominantly ocular phenotype suggestive of Stickler syndrome
- (2013) I. Schrauwen et al. CLINICAL GENETICS
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Programmed Cell Death in Animal Development and Disease
- (2011) Yaron Fuchs et al. CELL
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
- Treatment of kidney cancer
- (2010) William G. Kaelin CANCER
- Humans possess two mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis, heme, and Fe/S cluster biosynthesis
- (2010) A. D. Sheftel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More